Biostage, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
“Based on preclinical, large-animal studies conducted to date, we believe our Cellspan esophageal implants may have the potential to offer improved outcomes for patients by reducing post-operative complications and providing an improved quality of life, by prompting regeneration of the patient’s own esophagus”, said Jim McGorry, CEO of Biostage. Read the full article.
Biostage, Inc. is a biotechnology company, which is engaged in developing bioengineered organ implants based on its novel Cellframe technology. The Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own cells. It is engaged in the development and commercialization of regenerated organs for human transplant. Biostage was founded on May 3, 2012 and is headquartered in Holliston, MA. [Source: MarketWatch]